On May 11, 2026, a trial update was recorded for a Phase 4 study titled Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness. The trial, registered as NCT04427241, is listed with a status of recruiting.
This Phase 4 study is designed to evaluate cerebrolysin in patients with prolonged disorders of consciousness. According to the ClinicalTrials.gov record, the trial has not posted results and remains in the recruiting phase as of this update.
Cerebrolysin's regulatory status is unapproved for research use. No efficacy or safety outcomes have been reported for this trial as of the date of this update. The listing reflects only that recruitment is ongoing for a Phase 4 protocol.
Readers interested in background on this compound can consult the compound overview for additional context.